References
- Parvan PR, Margo CE. Submacular neovascular membrane and focal granulomatous inflammation. Ophthalmology. 1996;103:586–589. doi:https://doi.org/10.1016/S0161-6420(96)30649-0.
- Forrester JV, Liversidge J, Dua HS, Dick A, Harper F, McMenamin PG. Comparison of clinical experimental uveitis. Curr Eye Res. 1990;9:75–84. doi:https://doi.org/10.3109/02713689008999424.
- Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, et al. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 Years Among patients with intermediate, posterior, or panuveitis. JAMA. May 16, 2017;317(19):1993–2005. doi:https://doi.org/10.1001/jama.2017.5103.
- Ferrante P, Ramsey A, Bunce C, Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Exp Ophthalmol. 2004;32:563–568. doi:https://doi.org/10.1111/ceo.2004.32.issue-6.
- Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. October 2009;16(4):245–251. doi:https://doi.org/10.4103/0974-9233.58422.
- Llop SM, Papaliodis GN. Cataract surgery complications in uveitis patients: a review article. Semin Ophthalmol. 2018;33(1):64–69. doi:https://doi.org/10.1080/08820538.2017.1353815.
- Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. December 2004;13(6):461–465. doi:https://doi.org/10.1097/01.ijg.0000146391.77618.d0.
- Kilmartin DJ, Forrester JV, Dick AD. Cyclosporine-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia. Arch Ophthalmol. February 1998;116(2):249–250.
- Neri P, Manoni M, Fortuna C, Lettieri M, Mariotti C, Giovannini A. Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series. Int Ophthalmol. October 2010;30(5):583–590. doi:https://doi.org/10.1007/s10792-009-9323-x.
- Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendation for the evaluation of intraocular inflammatory diseases. Am J Ophthalmol. 1987;103:234–235. doi:https://doi.org/10.1016/S0002-9394(14)74235-7.
- Trusko B, Thorne J, Jabs D, et al. The Standardization of Uveitis Nomenclature (SUN) project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013;52(3):259–65, S1-6. doi:https://doi.org/10.3414/ME12-01-0063.
- McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. September 2018;125:15–24. doi:https://doi.org/10.1016/j.freeradbiomed.2018.03.042.
- Chen M, Rajapakse D, Fraczek M, Luo C, Forrester JV, Xu H. Retinal pigment epithelial cell multinucleation in the aging eye - a mechanism to repair damage and maintain homoeostasis. Aging Cell. June 2016;15(3):436–445. doi:https://doi.org/10.1111/acel.2016.15.issue-3.
- Balne PK, Agrawal R, Au VB, et al. Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy. Data Brief. May 2018;24(19):1570–1573. doi:https://doi.org/10.1016/j.dib.2018.05.085.
- Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond). 1998;12(Pt 2):266–272. doi:https://doi.org/10.1038/eye.1998.62.
- Rothova A. Corticosteroids in uveitis. Ophthalmol Clin North Am. September 2002;15(3):389–394. doi:https://doi.org/10.1016/S0896-1549(02)00023-8.
- Dibas A, Yorio T. Glucocorticoid therapy and ocular hypertension. Eur J Pharmacol. September 2016;15(787):57–71. doi:https://doi.org/10.1016/j.ejphar.2016.06.018.
- Dees C, Arnold JJ, Forrester JV, Dick AD. Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol. November 1998;116(11):1456–1461. doi:https://doi.org/10.1001/archopht.116.11.1456.
- Neri P, Mariotti C, Cimino L, Mercanti L, Giovannini A. Long-term control of cystoid macular oedema in noninfectious uveitis with mycophenolate mofetil. Int Ophthalmol. June 2009;29(3):127–133. doi:https://doi.org/10.1007/s10792-008-9200-z.
- Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. renal transplant mycophenolate mofetil study group. Transplantation. 1995;60:225–232. doi:https://doi.org/10.1097/00007890-199508000-00003.
- Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 1996;61:1029–1037. doi:https://doi.org/10.1097/00007890-199604150-00008.
- Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Wounde FJ. Mycophenolate mofetil for maintenance therapy of Wegener’s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol. September 1999;10(9):1965–1971.
- Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn’s disease?. Am J Gastroenterol. March 2001;96(3):782–787. doi:https://doi.org/10.1111/ajg.2001.96.issue-3.
- Jabs DA, Rosenbaum JT, Foster S, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513. doi:https://doi.org/10.1016/S0002-9394(00)00659-0.
- Kost RG, de Rosa JC. Impact of survey length and compensation on validity, reliability, and sample characteristics for ultrashort-, short-, and long-research participant perception surveys. J Clin Transl Sci. February 2018;2(1):31–37. doi:https://doi.org/10.1017/cts.2018.18.